Scientific Report 2017

EOC Academic Education, Research and Innovation Area
EOC Editorial Board:
Viale Officina 3
6500 Bellinzona
+41(0)91 811 13 10

Rapporto Scientifico 2017

Institute of Pharmacological Science Research Indietro

The Institute of Pharmacological Sciences of Southern Switzerland (ISFSI), established in 2017, includes the Division of Clinical Pharmacology and Toxicology, with its Clinical Services advising other Departments and physicians on safe drug therapy use and promoting the rational use of medicines, the Regional Pharmacovigilance Centre, and a small research and teaching unit, and the Central Pharmacy Service, with the Hospital Pharmacy, Clinical Pharmacy, and Public Pharmacy. Research activities focus mainly on improving drug safety, partly in cooperation with other clinical pharmacology and toxicology departments of Swiss university hospitals. We are now in the process of establishing a Pharmacoepidemiology Research Unit. Our ultimate goal is to personalise drug therapy by optimising beneficial effects and therefore, increasing drug safety while minimising adverse effects and costs.
The study Swiss Drug Emergency Network (Swiss-DEN): a multicenter analysis of acute recreational substance toxicity started in January 2017, and in July 2017 we were allowed to enter the Euro-DEN study as an official centre among other 29 centres in 20 European countries. ABREOC supports our centre.

Click on the link below to see more about the ISFSI report

Ultimo aggiornamento: 31 luglio 2018